Genzyme maps big plans for R&D, manufacturing expansion

Genzyme (NASDAQ: GENZ) isn't letting a little manufacturing crisis get in the way of its ambitious long-term growth plans. The big biotech outfit has blueprinted a massive 757,000-square-foot expansion at its Framingham, MA facility, with some 400,000 square feet of new space reserved for its research operations. The Boston Globe reports that state officials are reviewing plans for the new R&D complex along with added office and manufacturing capacity for its facility there. Henry...

Sanofi adding 300 workers in $65M Boston HQ expansion

On the heels of a string of new cancer licensing deals and biotech buyouts, Sanofi-Aventis says that it is preparing to lease space in Cambridge, MA for a new cancer division headquarters facility that will add about 300 high-paying jobs, according to a report in the Boston Globe. Sanofi officials made it clear that Cambridge's biotech cluster, home to some of the world's best-known cancer researchers, was a natural choice for the $65 million expansion effort. Sanofi's oncology chief,...